Imagion Biosystems Receives R&D Advanced Overseas Finding

Matthew Wygant Investor Updates

Imagion Biosystems is pleased to announce that it has successfully applied for an Advance/Overseas Finding in relation to its research and development activities for a new superparamagnetic based imaging technology for detection of HER2 breast cancers.

View the announcement.